Holen Sie sich die Stockscreener-App
50.48
1.95%
0.9717
Qiagen Nv Aktie (QGEN) Neueste Nachrichten
Why Qiagen (QGEN) is a Top Growth Stock for the Long-Term - Yahoo Finance
What drives Qiagen N.V. stock priceMarket-leading capital gains - Autocar Professional
QIAGEN Expands NGS Portfolio with Launch of QIAseq xHYB Long Read Panels - BioSpace
BlackRock’s Significant Stake in Qiagen Disclosed by AFM - TipRanks
QIAGEN launches long read sequencing panels for complex genomic analysis - StreetInsider
PTA-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG - TradingView
Release according to Article 40, Section 1 of the WpHG - TradingView
Qiagen N.V. Stock Analysis and ForecastUnmatched profit growth - jammulinksnews.com
Qiagen NV stock reaches 52-week high at 48.91 USD - Investing.com India
Is Qiagen N.V. a good long term investmentExceptional return forecasts - jammulinksnews.com
What analysts say about Qiagen N.V. stockMassive wealth growth - Autocar Professional
QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG - Pressetext
BofA Securities Maintains Qiagen NV(QGEN.US) With Buy Rating, Maintains Target Price $53 - 富途牛牛
Qiagen Announces Significant Voting Rights Notification by BlackRock - TipRanks
Favorable Government Support Fuels Germany's Biotech Innovation and Commercialization: Market to Surpass USD 94 Billion by 2034 Led by QIAGEN, Thermo Fisher Scientific, Illumina and Roche - Yahoo.co
Qiagen N.V. (NYSE:QGEN) is favoured by institutional owners who hold 79% of the company - simplywall.st
Fivespan Said to Build Stake in Life Sciences Group Qiagen - MSN
Qiagen and Gencurix partner for oncology tests - MSN
Qiagen NV stock hits 52-week high at 48.82 USD By Investing.com - Investing.com South Africa
QIAGEN Announces Managerial Share Transaction - TipRanks
Qiagen NV stock hits 52-week high at 48.82 USD - Investing.com Australia
QIAGEN N.V. to Release Results for Q2 2025 and Hold Webcast - Business Wire
QIAGEN NV : Deutsche Bank maintains a Buy rating - MarketScreener
Baptista Research Begins Qiagen Coverage at Hold - MarketScreener
Qiagen Teams With Gencurix to Expand Digital PCR Cancer Assays - MSN
Qiagen N : announces adjustment of conversion price under its US$500,000,000 Convertible Bonds due 2031 - MarketScreener
Qiagen N : announces adjustment of conversion price under its US$500,000,000 Convertible Bonds due 2027 - MarketScreener
Qiagen N.V.(NYSE: QGEN) dropped from Russell 1000 Dynamic Index - MarketScreener
Ex-Dividend Reminder: Comcast, Qiagen and HA Sustainable Infrastructure Capital - Nasdaq
Qiagen Announces Managerial Share Transaction - TipRanks
Qiagen N.V. (QGEN) Expands MRD Testing with Tracer and Foresight Partnerships - MSN
QIAGEN Announces Election of Stephen Rusckowski as Chairman of S - GuruFocus
Qiagen (QGEN) Target Price Raised by B of A Securities | QGEN Stock News - GuruFocus
QIAGEN Announces Election of Stephen Rusckowski as Chairman of Supervisory Board - Business Wire
Barclays Starts Qiagen NV (QGEN) at Overweight - StreetInsider
Here's Why Qiagen (QGEN) is a Strong Value Stock - Nasdaq
Qiagen Announces BlackRock’s Significant Voting Rights Disclosure - TipRanks
Qiagen (QGEN) Just Flashed Golden Cross Signal: Do You Buy? - Yahoo.co
Incyte (INCY) Teams Up with QIAGEN to Boost Blood Cancer Diagnostic Solutions - MSN
Here's Why Qiagen (QGEN) is a Strong Growth Stock - Nasdaq
3.01%
1.70%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):